Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Grassi

Showing results (661-670 of 808) with videos related to

Pageof 81
Sort By:
Journal of Hypertension|July 2, 2015
Long-term chronic baroreflex activation: persistent efficacy in patients with heart failure and reduced ejection fractionEdoardo Gronda, Gino Seravalle, Fosca Quarti Trevano, et al.
Annals of Vascular Surgery|July 26, 2019
Cardiovascular Remodeling after Endovascular Treatment for Thoracic Aortic InjuryPaola Vallerio, Alessandro Maloberti, Ilenia D'Alessio, et al.
Journal of Hypertension|May 1, 2024
Beta-blocker bashing and downgrading in hypertension management: a fashionable trend representing a matter of concernReinhold Kreutz, Mattias Brunström, Michel Burnier, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|November 25, 2017
Sex-related relationships between uric acid and target organ damage in hypertensionAlessandro Maloberti, Simone Maggioni, Lucia Occhi, et al.
Hypertension (Dallas, Tex. : 1979)|March 13, 2024
Rationale for the Inclusion of β-Blockers Among Major Antihypertensive Drugs in the 2023 European Society of Hypertension GuidelinesGiuseppe Mancia, Mattias Brunström, Michel Burnier, et al.
Blood Pressure|February 26, 2024
Why were the 2023 Guidelines of the European Society of Hypertension not developed as Joint Guidelines together with the European Society of Cardiology?Reinhold Kreutz, Michel Azizi, Guido Grassi, et al.
The Journal of Physical Chemistry Letters|September 9, 2016
Synchrotron-Based Highest Resolution Terahertz Spectroscopy of the ν<sub>24</sub> Band System of 1,2-Dithiine (C<sub>4</sub>H<sub>4</sub>S<sub>2</sub>): A Candidate for Measuring the Parity Violating Energy Difference between Enantiomers of Chiral MoleculesSieghard Albert, Fabienne Arn, Irina Bolotova, et al.
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|November 20, 2025
Rationale for the Use of Fixed Combination Therapies with Angiotensin Converting Enzyme Inhibitors and Beta-Blockers in Patients with Essential Hypertension and High Cardiovascular Risk: A Consensus Document from the Italian Society of Arterial Hypertension (Siia) and the Italian Society of Cardiovascular Prevention (SIPREC)Agostino Virdis, Giuliano Tocci, Maria Lorenza Muiesan, et al.
Metabolism: Clinical and Experimental|July 13, 2012
Effect of a somatostatin infusion on circulating levels of adipokines in obese womenAntonello E Rigamonti, Alessandro Sartorio, Sara M Bonomo, et al.
Blood Pressure|November 5, 2011
Early alterations in left ventricular diastolic function in normotensive diabetic patientsAnna Capra, Maurizio Galderisi, Cristina Giannattasio, et al.
Pageof 81

Showing results (661-670 of 808) with videos related to

Sort By:
Pageof 81
Journal of Hypertension|July 2, 2015
Long-term chronic baroreflex activation: persistent efficacy in patients with heart failure and reduced ejection fractionEdoardo Gronda, Gino Seravalle, Fosca Quarti Trevano, et al.
Annals of Vascular Surgery|July 26, 2019
Cardiovascular Remodeling after Endovascular Treatment for Thoracic Aortic InjuryPaola Vallerio, Alessandro Maloberti, Ilenia D'Alessio, et al.
Journal of Hypertension|May 1, 2024
Beta-blocker bashing and downgrading in hypertension management: a fashionable trend representing a matter of concernReinhold Kreutz, Mattias Brunström, Michel Burnier, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|November 25, 2017
Sex-related relationships between uric acid and target organ damage in hypertensionAlessandro Maloberti, Simone Maggioni, Lucia Occhi, et al.
Hypertension (Dallas, Tex. : 1979)|March 13, 2024
Rationale for the Inclusion of β-Blockers Among Major Antihypertensive Drugs in the 2023 European Society of Hypertension GuidelinesGiuseppe Mancia, Mattias Brunström, Michel Burnier, et al.
Blood Pressure|February 26, 2024
Why were the 2023 Guidelines of the European Society of Hypertension not developed as Joint Guidelines together with the European Society of Cardiology?Reinhold Kreutz, Michel Azizi, Guido Grassi, et al.
The Journal of Physical Chemistry Letters|September 9, 2016
Synchrotron-Based Highest Resolution Terahertz Spectroscopy of the ν<sub>24</sub> Band System of 1,2-Dithiine (C<sub>4</sub>H<sub>4</sub>S<sub>2</sub>): A Candidate for Measuring the Parity Violating Energy Difference between Enantiomers of Chiral MoleculesSieghard Albert, Fabienne Arn, Irina Bolotova, et al.
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|November 20, 2025
Rationale for the Use of Fixed Combination Therapies with Angiotensin Converting Enzyme Inhibitors and Beta-Blockers in Patients with Essential Hypertension and High Cardiovascular Risk: A Consensus Document from the Italian Society of Arterial Hypertension (Siia) and the Italian Society of Cardiovascular Prevention (SIPREC)Agostino Virdis, Giuliano Tocci, Maria Lorenza Muiesan, et al.
Metabolism: Clinical and Experimental|July 13, 2012
Effect of a somatostatin infusion on circulating levels of adipokines in obese womenAntonello E Rigamonti, Alessandro Sartorio, Sara M Bonomo, et al.
Blood Pressure|November 5, 2011
Early alterations in left ventricular diastolic function in normotensive diabetic patientsAnna Capra, Maurizio Galderisi, Cristina Giannattasio, et al.
Pageof 81